Get comparisons, analyses and forecasts for stocks, ETFs & funds
AADR vs CHNA
AADR is an ETF, whereas CHNA is a mutual fund. AADR has a higher expense ratio than CHNA (1.1% vs 0.79%). Below is the comparison between AADR and CHNA.
AADR | CHNA | |
---|---|---|
Security Type | ETF | Mutual fund |
Segment | Equity: Global Ex-U.S. - Total Market Growth | N/A |
Issuer | AdvisorShares | Loncar Investments |
Net Assets | $77.9M | $13.7M |
Expense Ratio | 1.10% | 0.79% |
Management Style | passive (index-based) | passive |
Dividend Yield | 0.11% | 0.41% |
Minimum Investment | N/A | N/A |
YTD Return | 2.99% | 16.33% |
1-Year Return | 27.16% | 24.16% |
3-Year Return | 1.67% | N/A |
5-Year Return | 12.36% | N/A |
10-Year Return | 8.08% | N/A |
AADR description
The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.
AADR performance & returns
YTD Return | 2.99% |
1-Month Return | 4.24% |
3-Month Return | 8.65% |
1-Year Return | 27.16% |
3-Year Return | 1.67% |
5-Year Return | 12.36% |
10-Year Return | 8.08% |
AADR holdings
Top 10 Holdings (45.63% of Total Assets)
Name | Symbol | % Assets |
---|---|---|
MercadoLibre Inc | MELI.SA | 7.21% |
NICE Ltd ADR | NICE | 6.54% |
Gold Fields Ltd ADR | GFI.JO | 5.86% |
argenx SE ADR | ARGX | 5.52% |
Anglogold Ashanti Ltd ADR | AU.JO | 3.64% |
TAL Education Group ADR | TAL | 3.63% |
ASML Holding NV ADR | ASML | 3.59% |
ZTO Express (Cayman) Inc ADR | ZTO | 3.35% |
Sibanye Stillwater Ltd ADR | SBSW.JO | 3.21% |
LVMH Moet Hennessy Louis Vuitton SE ADR | LVMUY.PA | 3.08% |
Other relevant AADR comparisons
You may also want to check out the following AADR comparisons that investors often look for on Finny
CHNA description
The Fund seeks to track the performance of the Loncar China BioPharma Index. The Fund invests at least 80% of its assets in the component securities of the Index constructed from the universe of Nasdaq- or Hong Kong Stock Exchange-listed companies identified by the Index methodology as Biopharma Companies.
CHNA performance & returns
YTD Return | 16.33% |
1-Month Return | 3.62% |
3-Month Return | 24.16% |
1-Year Return | 24.16% |
3-Year Return | N/A |
5-Year Return | N/A |
10-Year Return | N/A |
CHNA holdings
Top 10 Holdings (32.44% of Total Assets)
Name | Symbol | % Assets |
---|---|---|
BeiGene Ltd ADR | BGNE | 4.09% |
WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S | 02269 | 4.02% |
Pharmaron Beijing Co Ltd Ordinary Shares - Class H | 03759 | 4.02% |
Hansoh Pharmaceutical Group Co Ltd | 03692 | 3.37% |
Wuxi AppTec Co Ltd | 02359 | 3.14% |
I-MAB ADR | IMAB | 3.14% |
Burning Rock Biotech Ltd ADR | BNR | 2.89% |
Shanghai Junshi Biosciences Co Ltd Class H | 01877 | 2.75% |
CSPC Pharmaceutical Group Ltd | 01093 | 2.53% |
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H | 02196 | 2.49% |
Other relevant CHNA comparisons
You may also want to check out the following CHNA comparisons that investors often look for on Finny
You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.